by Anna Sauerbier
Research and Innovation performance and Horizon 2020 country participation
Health at a Glance: Chronic disease costs European economy €115B a year
Public-private European partnership (ROADMAP) paves the way for sustainable platform for the generation and analysis of real world evidence in Alzheimer’s disease
A new super-resolution imaging technique allows researchers to track how surface changes in proteins are related to neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseases.
Rising dementia numbers in EU causes alarm
Survey shows cancer patients want clear information on treatments -Patients can play active role in shaping drug development and treatment goals, but they need intelligible information to do so
Targeting brain chemistry to beat disease – Diagnosing and treating neuropsychiatric disorders are among the biggest challenges in modern medicine. While the brain is highly complex, scientists have been learning more about how it works – and what happens when things go wrong.
New drug capsule delivers medicine for weeks after swallowing
After blindness, the adult brain can learn to see again